Johnson & Johnson Innovative Medicine is recruiting for Director, Global Commercial Lead, Bladder Cancer, TAR 210 (ErdaiDRS) to be located at our Raritan, NJ. About Oncology Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine Purpose: the Director, Global Commercial Lead, Bladder Cancer, TAR 210 (ErdaiDRS) reports to the Sr. Director, Global Commercial Strategy, Bladder Cancer, TAR 210. The Director is responsible for owning & leading the commercial strategy, launch excellence, market shaping & development efforts, customer solutions, go-to-market model, and LCM efforts for TAR 210 (ErdaiDRS). The role will contribute to optimizing the value of our global J&J Bladder Cancer portfolio, by collaboration with key functions across the Global Commercial Strategy Organization (GCSO), J&J Research and Development (R&D), and J&J business regions. The colleague is a leader within the TAR 210 Compound Development Team (CDT).
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees